BBLGW

Bone Biologics Corporation [BBLGW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BBLGW Stock Summary

In the News

BBLGW Financial details

Company Rating
Sell
Market Cap
1.86M
Income
-9.51M
Revenue
0
Book val./share
5.44
Cash/share
5.67
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-6.14
Forward P/E
-
PEG
0.08
P/S
-
P/B
11.44
P/C
3.03
P/FCF
-0.27
Quick Ratio
3.76
Current Ratio
4.21
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-13.15
EPS next Y
-
EPS next Q
-
EPS this Y
-1958.47%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
375.41%
-
-
-
-
SMA20
216.67%
SMA50
375%
SMA100
533.33%
Inst Own
1.06%
Inst Trans
0.74%
ROA
-142%
ROE
-155%
ROC
-2.52%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
108.87K
Shs Float
100.34K
-
-
-
-
Target Price
-
52W Range
0.019-44.145
52W High
-
52W Low
-
RSI
60
Rel Volume
-
Avg Volume
3.39K
Volume
1
Perf Week
-18.1%
Perf Month
-9.47%
Perf Quarter
68.96%
Perf Half Y
45.52%
-
-
-
-
Beta
0.586
-
-
Volatility
1.64%, 6.81%
Prev Close
0%
Price
17.2
Change
1.53%

BBLGW Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-35.23-18.8-10.641.83-34.01
Operating cash flow per share
-33.45-4.4-8.12-9.37-36.32
Free cash flow per share
-33.45-4.4-8.12-9.37-36.32
Cash per share
0.25044.0919.811.5
Book value per share
-122.08-141.0943.4315.6211.05
Tangible book value per share
-122.08-141.0943.4315.6211.05
Share holders equity per share
-122.08-141.0943.4315.6211.05
Interest debt per share
106.41131.085.32-7.780
Market cap
283.16M282.68M128.03M19.18M1.19M
Enterprise value
294.45M294.4M121.35M11.64M-1.84M
P/E ratio
-82.68-154.92-79.4927.56-0.13
Price to sales ratio
00000
POCF ratio
-87.09-662.12-104.21-5.38-0.12
PFCF ratio
-87.09-662.12-104.21-5.38-0.12
P/B Ratio
-23.86-20.6519.473.230.41
PTB ratio
-23.86-20.6519.473.230.41
EV to sales
00000
Enterprise value over EBITDA
-120.31-356.85-110.17-2.650.19
EV to operating cash flow
-90.57-689.58-98.77-3.260.19
EV to free cash flow
-90.57-689.58-98.77-3.260.19
Earnings yield
-0.01-0.01-0.010.04-7.52
Free cash flow yield
-0.010-0.01-0.19-8.03
Debt to equity
-0.95-0.860-0.130
Debt to assets
367.2100-0.090
Net debt to EBITDA
-4.62-14.216.061.710.32
Current ratio
0.05066.813.334.5
Interest coverage
2.51-0.83-1.371.680
Income quality
0.950.230.762.41.07
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
311.09244.32101.9625.3491.93
ROIC
4.470.42-0.170.33-3.24
Return on tangible assets
-111.10-0.240.08-2.39
Graham Net
-122.15-141.0943.4313.498.65
Working capital
-547.62K-13.69M6.58M5.95M2.91M
Tangible asset value
-11.87M-13.69M6.58M5.95M2.91M
Net current asset value
-11.87M-13.69M6.58M5.95M2.91M
Invested capital
-0.95-0.860-0.130
Average receivables
000289.96K454.38K
Average payables
84.04K254.14K282.65K50.4K180.78K
Average inventory
000-289.96K-454.38K
Days sales outstanding
00000
Days payables outstanding
313.02K0000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.290.13-0.240.12-3.08
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
6.3-7.95-1.69-0.61-2.9
Operating cash flow per share
-4-2.51-3.47-0.82-3.78
Free cash flow per share
-4-2.51-3.47-0.82-3.78
Cash per share
15.4511.526.691.425.67
Book value per share
12.195.165.441.215.44
Tangible book value per share
12.195.165.441.215.44
Share holders equity per share
12.195.165.441.215.44
Interest debt per share
-6.071.05000
Market cap
24.59M33.36M11.98M17.8M2.41M
Enterprise value
17.05M27.17M4.97M13.35M-611.81K
P/E ratio
2-1.95-1.69-2.32-0.39
Price to sales ratio
00000
POCF ratio
-12.6-24.71-3.3-6.97-1.2
PFCF ratio
-12.6-24.71-3.3-6.97-1.2
P/B Ratio
4.1312.032.14.690.83
PTB ratio
4.1312.032.14.690.83
EV to sales
00000
Enterprise value over EBITDA
19.12-10.51-1.15-6.420.79
EV to operating cash flow
-8.74-20.13-1.37-5.220.3
EV to free cash flow
-8.74-20.13-1.37-5.220.3
Earnings yield
0.12-0.13-0.15-0.11-0.64
Free cash flow yield
-0.08-0.04-0.3-0.14-0.84
Debt to equity
-0.130000
Debt to assets
-0.090000
Net debt to EBITDA
-8.452.391.632.143.93
Current ratio
3.331.693.954.214.5
Interest coverage
0.59-5.6000
Income quality
-2.180.362.051.331.3
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
41.5530.3914.384.0818.84
ROIC
-0.86-1.31-0.53-0.55-0.4
Return on tangible assets
0.36-0.63-0.23-0.39-0.41
Graham Net
10.524.054.851.044.26
Working capital
5.95M2.77M5.69M3.79M2.91M
Tangible asset value
5.95M2.77M5.69M3.79M2.91M
Net current asset value
5.95M2.77M5.69M3.79M2.91M
Invested capital
-0.130000
Average receivables
289.96K289.96K00164.42K
Average payables
843.97K1.58M1.98M1.4M731.69K
Average inventory
-289.96K-289.96K00-164.42K
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.52-1.54-0.31-0.51-0.53
Capex per share
00000

BBLGW Frequently Asked Questions

What is Bone Biologics Corporation stock symbol ?

Bone Biologics Corporation is a US stock , located in Burlington of Ma and trading under the symbol BBLGW

What is Bone Biologics Corporation stock quote today ?

Bone Biologics Corporation stock price is $17.2 today.

Is Bone Biologics Corporation stock public?

Yes, Bone Biologics Corporation is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Same Price Range
Similar Market Cap